Ignite Creation Date:
2024-05-05 @ 7:43 PM
Last Modification Date:
2024-10-26 @ 9:52 AM
Study NCT ID:
NCT00720135
Status:
COMPLETED
Last Update Posted:
2015-06-08
First Post:
2008-07-19
Brief Title:
Fusion Protein Cytokine Therapy After Rituximab in Treating Patients With B-Cell Non-Hodgkin Lymphoma
Sponsor:
City of Hope Medical Center
Organization:
City of Hope Medical Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Waldenstrom Macroglobulinemia |
| Anaplastic Large Cell Lymphoma |
| Cutaneous B-cell Non-Hodgkin Lymphoma |
| Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue |
| Intraocular Lymphoma |
| Nodal Marginal Zone B-cell Lymphoma |
| Recurrent Adult Diffuse Small Cleaved Cell Lymphoma |
| Recurrent Adult Grade III Lymphomatoid Granulomatosis |
| Recurrent Grade 1 Follicular Lymphoma |
| Recurrent Grade 2 Follicular Lymphoma |
| Recurrent Marginal Zone Lymphoma |
| Small Intestine Lymphoma |
| Splenic Marginal Zone Lymphoma |
| Testicular Lymphoma |
Keywords: